|
66
|
251
|
5ayfA |
Crystal structure of set7/9 in complex with cyproheptadine |
|
10
|
29
|
5gsaC |
Eed in complex with an allosteric prc2 inhibitor |
|
47
|
217
|
4ypeA |
Ash1l set domain h2193f mutant in complex with s-adenosyl methionine (sam) |
|
38
|
154
|
5f59A |
The crystal structure of mll3 set domain |
|
44
|
156
|
5f6lA |
The crystal structure of mll1 (n3861i/q3867l) in complex with rbbp5 and ash2l |
|
143
|
425
|
5arfA |
Smyd2 in complex with small molecule inhibitor compound-2 |
|
34
|
158
|
5f6kC |
Crystal structure of the mll3-ash2l-rbbp5 complex |
|
147
|
429
|
5ex0A |
Crystal structure of human smyd3 in complex with a map3k2 peptide |
|
151
|
426
|
5argA |
Smyd2 in complex with sgc probe bay-598 |
|
98
|
327
|
5dt2A |
Crystal structure of dot1l in complex with inhibitor cpd11 [n4-methyl-n2-(2-methyl-1-(2-phenoxyphenyl)-1h-indol-6-yl)pyrimidine-2,4-diamine] |
|
145
|
428
|
5ex3A |
Crystal structure of human smyd3 in complex with a vegfr1 peptide |
|
71
|
248
|
5eg2A |
Set7/9 n265a in complex with adohcy and taf10 peptide |
|
40
|
156
|
5f5eA |
The crystal structure of mll1 set domain with n3816i/q3867l mutation |
|
100
|
328
|
5dryA |
Crystal structure of dot1l in complex with inhibitor cpd3 [n-(1-(2-chlorophenyl)-1h-indol-6-yl)-2-(2-(5-(2-chlorophenyl)-1h-tetrazol-1-yl)acetyl)hydrazinecarboxamide] |
|
105
|
328
|
5dtrA |
Crystal structure of dot1l in complex with inhibitor cpd5 [n-(2,6-dichlorophenyl)-4-methoxy-n-methylquinolin-6-amine] |
|
105
|
328
|
5dsxA |
Crystal structure of dot1l in complex with inhibitor cpd10 [6'-chloro-1,4-dimethyl-5'-(2-methyl-6-((4-(methylamino)pyrimidin-2-yl)amino)-1h-indol-1-yl)-[3,3'-bipyridin]-2(1h)-one] |
|
97
|
328
|
5drtA |
Crystal structure of dot1l in complex with inhibitor cpd2 [2-(2-(5-((2-chlorophenoxy)methyl)-1h-tetrazol-1-yl)acetyl)-n-(4-chlorophenyl)hydrazinecarboxamide] |
|
103
|
328
|
5dtqA |
Crystal structure of dot1l in complex with inhibitor cpd3 [(2,6-dichlorophenyl)(quinolin-6-yl)methanone] |
|
102
|
328
|
5dtmA |
Crystal structure of dot1l in complex with inhibitor cpd1 [4-(2,6-dichlorobenzoyl)-n-methyl-1h-pyrrole-2-carboxamide] |
|
49
|
215
|
4ynmA |
Ash1l wild-type set domain in complex with s-adenosyl methionine (sam) |
|
48
|
218
|
4ypaA |
Ash1l set domain q2265a mutant in complex with s-adenosyl methionine (sam) |
|
132
|
428
|
4yndA |
The discovery of a-893, a new cell-active benzoxazinone inhibitor of lysine methyltransferase smyd2 |
|
45
|
213
|
4ynpA |
Ash1l set domain s2259m mutant in complex with s-adenosyl methionine (sam) |
|
67
|
263
|
5cprB |
The novel suv4-20 inhibitor a-196 verifies a role for epigenetics in genomic integrity |
|
145
|
429
|
4wuyA |
Crystal structure of protein lysine methyltransferase smyd2 in complex with lly-507, a cell-active, potent and selective inhibitor |
|
107
|
344
|
4wvlA |
Structure-guided dot1l probe optimization by label-free ligand displacement |
|
28
|
108
|
4rxjA |
Crystal structure of whsc1l1-pwwp2 |
|
145
|
430
|
4o6fA |
Structural basis of estrogen receptor alpha methylation mediated by histone methyltransferase smyd2 |
|
148
|
500
|
4nj5A |
Crystal structure of suvh9 |
|
70
|
272
|
4nvqA |
Human g9a in complex with inhibitor a-366 |
|
69
|
217
|
4o30A |
Crystal structure of atxr5 in complex with histone h3.1 and adohcy |
|
45
|
214
|
4mi5A |
Crystal structure of the ezh2 set domain |
|
46
|
210
|
4mi0A |
Human enhancer of zeste (drosophila) homolog 2(ezh2) |
|
18
|
65
|
4l58A |
Crystal structure of the mll5 phd finger in complex with h3k4me3 |
|
64
|
247
|
4jlgA |
Setd7 in complex with inhibitor (r)-pfi-2 and s-adenosyl-methionine |
|
68
|
246
|
4j7fA |
Set7/9y335paf in complex with taf10 peptide and adohcy |
|
69
|
254
|
4jdsA |
Setd7 in complex with inhibitor pf-5426 and s-adenosyl-methionine |
|
68
|
247
|
4j83A |
Set7/9 in complex with taf10k189a peptide and adomet |
|
44
|
161
|
4ij8A |
Crystal structure of the complex of setd8 with sam |
|
59
|
249
|
4j7iA |
Set7/9y335f in complex with taf10 peptide and adohcy |
|
69
|
261
|
4i51A |
Methyltransferase domain of human euchromatic histone methyltransferase 1, mutant y1211a |
|
55
|
219
|
4ijdA |
Crystal structure of methyltransferase domain of human pr domain-containing protein 9 |
|
66
|
249
|
4j8oA |
Set7/9 in complex with taf10k189a peptide and adohcy |
|
88
|
331
|
4hraA |
Crystal structure of dot1l in complex with epz-5676 |
|
60
|
245
|
4h12A |
The crystal structure of methyltransferase domain of human set domain-containing protein 2 in complex with s-adenosyl-l-homocysteine |
|
0
|
12
|
4gq6B |
Human menin in complex with mll peptide |
|
18
|
95
|
4gngA |
Crystal structure of nsd3 tandem phd5-c5hch domains complexed with h3k9me3 peptide |
|
19
|
98
|
4gndA |
Crystal structure of nsd3 tandem phd5-c5hch domains |
|
20
|
96
|
4gnfA |
Crystal structure of nsd3 tandem phd5-c5hch domains complexed with h3 peptide 1-15 |
|
20
|
98
|
4gneA |
Crystal structure of nsd3 tandem phd5-c5hch domains complexed with h3 peptide 1-7 |
